USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
VIRONIKA, LLC
Address:
3601 Spruce Street
Suite G63
Philadelphia, PA
Phone:
N/A
URL:
N/A
EIN:
126118564
DUNS:
808308170
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $605,401.00 2

Award List:

Novel Inhibitors of Latent Epstein Barr Virus Infection

Award Year / Program / Phase:
2009 / SBIR / Phase I
Award Amount:
$268,700.00
Agency:
HHS
Principal Investigator:
Troy Messick
Abstract:
DESCRIPTION (provided by applicant): The product that will result from this SBIR program, proposed by Vironika and its consortium partner, The Wistar Institute, is a new (the first) small molecule drug candidate for Epstein-Barr virus (EBV) latent infectio n, and its associated pathologies. EBV is a… More

Development of a Small Molecule Inhibitor for EBV Latent Infection

Award Year / Program / Phase:
2012 / SBIR / Phase I
Award Amount:
$336,701.00
Agency:
HHS
Principal Investigator:
Mark Mcdonnell – 215-589-6415
Abstract:
DESCRIPTION (provided by applicant): The goal of this SBIR research program is to develop a novel small molecule inhibitor of latent Epstein-Barr Virus (EBV) infection. EBV is a ubiquitous gamma- herpesvirus that has been classified by the World Health Organization as a human carcinogen. Vironika,… More